B2B SaaS Provider · vs · Other / Non-Digital Advertising Relevant

CGI vs Western Union

Structured technology and market comparison · 2026

Direct Feature Comparison

CGI · vs · Western Union
Primary Market / Role
CGIB2B SaaS Provider
Western UnionOther / Non-Digital Advertising Relevant
Platform Focus
CGI

Enterprise consulting and vertical software provider for regulated industries.

Western Union

Cross-border payments and remittance platform for consumers and businesses.

Company Size
CGI>5,000 employees
Western Union>5,000 employees
Headquarters
CGICA
Western UnionUS
Year Founded
CGI1976
Western UnionUnknown

Comparison Analysis

What is the main difference between CGI and Western Union?

When comparing CGI and Western Union, both platforms operate within the Payment Gateway & Orchestration ecosystem. CGI is positioned as Enterprise consulting and vertical software provider for regulated industries, whereas Western Union focuses on Cross-border payments and remittance platform for consumers and businesses. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to CGI and Western Union?

When evaluating CGI and Western Union, enterprise buyers also consider other platforms in Payment Gateway & Orchestration. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

Market Signals

Recent Market Signals & Activity: CGI vs Western Union

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

CGI

Recent Signals

  • ·SEC APIfinancials

    10-Q Financial Filing Analysis for CGI (2026-07-29)

    Corcept Therapeutics reported strong financial results for the second quarter ended June 30, 2026, generating net product revenue of $256.1 million, a 31.7% increase year-over-year. Growth was accelerated by the commercial launch of Lifyorli (relacorilant) in combination with nab-paclitaxel for platinum-resistant ovarian cancer, which contributed $47.6 million in debut quarterly sales alongside core hypercortisolism therapies. On the regulatory and legal front, Corcept resubmitted its relacorilant NDA for endogenous Cushing's syndrome with a PDUFA date set for December 17, 2026, while the Court of Appeals affirmed a non-infringement ruling in the Teva patent litigation and denied a rehearing en banc in July 2026.

    • Q2 2026 net product revenue rose 31.7% year-over-year to $256.1 million, bolstered by $47.6 million in initial sales from newly launched Lifyorli.
    • Corcept resubmitted its New Drug Application (NDA) for relacorilant in endogenous Cushing's syndrome on June 17, 2026, establishing an FDA PDUFA target action date of December 17, 2026.
    • The Court of Appeals affirmed a District Court ruling of non-infringement in the Teva patent litigation, with a petition for rehearing en banc denied in July 2026.
  • ·PR Newswire: Advertising & MarketingFinancials

    CGI Prices C$500 Million Senior Notes Offering

    CGI Inc. has priced a private offering of C$500 million in senior unsecured notes, split equally between 3.25-year and 4.75-year maturities, with interest rates of 4.195% and 4.484% respectively. The offering is expected to close around September 14, 2026, and the net proceeds of approximately C$497.3 million will be used to repay existing indebtedness and for general corporate purposes. The notes are being offered in Canada on a private placement basis through a syndicate of agents led by major Canadian financial institutions including Scotiabank, Desjardins, BMO, CIBC, National Bank, RBC, and TD Securities. This financing move is part of CGI's capital management strategy to optimize its debt structure, reflecting the company's strong market position and liquidity management.

    • CGI priced C$500 million in senior unsecured notes, split into two series of C$250 million each.
    • The notes carry interest rates of 4.195% (3.25-year) and 4.484% (4.75-year).
    • Net proceeds of ~C$497.3 million will be used for debt repayment and general corporate purposes.
  • ·CGI Investor Relations

    CGI to release third quarter fiscal 2026 results on July 29

    CGI to release third quarter fiscal 2026 results on July 29

Western Union

Recent Signals

No recent market signals documented for Western Union in the current tracking window.

Compare their exact ecosystem overlaps.

Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners CGI and Western Union share across the market ecosystem.